Adam R. Levy Sells 4,000 Shares of NEXGEL, Inc. (NASDAQ:NXGL) Stock

NEXGEL, Inc. (NASDAQ:NXGL) CEO Adam R. Levy sold 4,000 shares of the company’s stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $3.16, for a total transaction of $12,640.00. Following the completion of the transaction, the chief executive officer now owns 374,284 shares in the company, valued at approximately $1,182,737.44. This trade represents a 1.06 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.

NEXGEL Trading Up 2.5 %

Shares of NXGL traded up $0.07 during mid-day trading on Wednesday, reaching $2.84. The company had a trading volume of 41,192 shares, compared to its average volume of 101,705. The stock has a market cap of $19.29 million, a price-to-earnings ratio of -4.90 and a beta of 0.57. The company has a current ratio of 1.51, a quick ratio of 0.93 and a debt-to-equity ratio of 0.19. The firm has a fifty day simple moving average of $3.56 and a 200-day simple moving average of $3.26. NEXGEL, Inc. has a fifty-two week low of $1.84 and a fifty-two week high of $5.10.

Hedge Funds Weigh In On NEXGEL

A number of large investors have recently modified their holdings of NXGL. Renaissance Technologies LLC grew its holdings in shares of NEXGEL by 456.4% during the 4th quarter. Renaissance Technologies LLC now owns 158,331 shares of the company’s stock worth $706,000 after purchasing an additional 129,876 shares during the period. Northeast Financial Group Inc. grew its stake in NEXGEL by 168.8% during the third quarter. Northeast Financial Group Inc. now owns 31,848 shares of the company’s stock worth $82,000 after buying an additional 20,000 shares during the period. Two Sigma Securities LLC acquired a new stake in shares of NEXGEL in the fourth quarter worth $54,000. IFP Advisors Inc purchased a new position in shares of NEXGEL in the 4th quarter valued at $49,000. Finally, Virtu Financial LLC purchased a new position in shares of NEXGEL in the 4th quarter valued at $48,000. 2.21% of the stock is currently owned by hedge funds and other institutional investors.

NEXGEL Company Profile

NEXGEL, Inc manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc and changed its name to NEXGEL, Inc in November 2019.